GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia

E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300

(2012) Brandy D. Hyndman et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation

(2011) Brandy D. Hyndman et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Romidepsin: a novel histone deacetylase inhibitor for cancer

(2011) Erin M Bertino et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Histone acetyltransferase inhibitors and preclinical studies

(2009) Fabio Manzo et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1

(2009) Jürgen S. Scheele et al.   LEUKEMIA & LYMPHOMA

The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity

(2009) Magnus L. Hansson et al.   NUCLEIC ACIDS RESEARCH